{"id":"https://openalex.org/W4412189596","doi":"https://doi.org/10.1007/s00277-025-06471-2","title":"Cladribine and medium-dose cytarabine intensified busulfan plus cyclophosphamide conditioning regimen for adults high-risk B-cell acute lymphoblastic leukemia","display_name":"Cladribine and medium-dose cytarabine intensified busulfan plus cyclophosphamide conditioning regimen for adults high-risk B-cell acute lymphoblastic leukemia","publication_year":2025,"publication_date":"2025-07-01","ids":{"openalex":"https://openalex.org/W4412189596","doi":"https://doi.org/10.1007/s00277-025-06471-2","pmid":"https://pubmed.ncbi.nlm.nih.gov/40643599","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/12334429"},"language":"en","primary_location":{"id":"doi:10.1007/s00277-025-06471-2","doi":"https://doi.org/10.1007/s00277-025-06471-2","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s00277-025-06471-2","pdf_url":"https://link.springer.com/content/pdf/10.1007/s00277-025-06471-2.pdf","source":{"id":"https://openalex.org/S163204731","display_name":"Annals of Hematology","issn_l":"0939-5555","issn":["0939-5555","1432-0584"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Hematology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://link.springer.com/content/pdf/10.1007/s00277-025-06471-2.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5021869615","display_name":"Tingting Cheng","orcid":"https://orcid.org/0000-0003-4198-079X","observed_orcids":["https://orcid.org/0000-0003-4198-079X"]},"institutions":[{"id":"https://openalex.org/I139660479","display_name":"Central South University","ror":"https://ror.org/00f1zfq44","country_code":"CN","type":"education","lineage":["https://openalex.org/I139660479"]},{"id":"https://openalex.org/I4210159865","display_name":"Xiangya Hospital Central South University","ror":"https://ror.org/05c1yfj14","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210159865"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Tingting Cheng","raw_affiliation_strings":["Department of Hematology, Xiangya Hospital, Central South University, Changsha, China","Hunan Hematology Oncology Clinical Medical Research Center, Changsha, China","National Clinical Research Center for Geriatric Diseases (Xiangya Hospital), Changsha, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Xiangya Hospital, Central South University, Changsha, China","institution_ids":["https://openalex.org/I139660479","https://openalex.org/I4210159865"]},{"raw_affiliation_string":"Hunan Hematology Oncology Clinical Medical Research Center, Changsha, China","institution_ids":[]},{"raw_affiliation_string":"National Clinical Research Center for Geriatric Diseases (Xiangya Hospital), Changsha, China","institution_ids":["https://openalex.org/I4210159865"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100663197","display_name":"Jie Peng","orcid":"https://orcid.org/0000-0001-8907-701X","observed_orcids":["https://orcid.org/0000-0001-8907-701X"]},"institutions":[{"id":"https://openalex.org/I139660479","display_name":"Central South University","ror":"https://ror.org/00f1zfq44","country_code":"CN","type":"education","lineage":["https://openalex.org/I139660479"]},{"id":"https://openalex.org/I4210159865","display_name":"Xiangya Hospital Central South University","ror":"https://ror.org/05c1yfj14","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210159865"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Jie Peng","raw_affiliation_strings":["Department of Hematology, Xiangya Hospital, Central South University, Changsha, China","Hunan Hematology Oncology Clinical Medical Research Center, Changsha, China","National Clinical Research Center for Geriatric Diseases (Xiangya Hospital), Changsha, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Xiangya Hospital, Central South University, Changsha, China","institution_ids":["https://openalex.org/I139660479","https://openalex.org/I4210159865"]},{"raw_affiliation_string":"Hunan Hematology Oncology Clinical Medical Research Center, Changsha, China","institution_ids":[]},{"raw_affiliation_string":"National Clinical Research Center for Geriatric Diseases (Xiangya Hospital), Changsha, China","institution_ids":["https://openalex.org/I4210159865"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100330583","display_name":"Yi Liu","orcid":"https://orcid.org/0000-0002-9234-5457","observed_orcids":["https://orcid.org/0000-0002-9234-5457"]},"institutions":[{"id":"https://openalex.org/I139660479","display_name":"Central South University","ror":"https://ror.org/00f1zfq44","country_code":"CN","type":"education","lineage":["https://openalex.org/I139660479"]},{"id":"https://openalex.org/I4210159865","display_name":"Xiangya Hospital Central South University","ror":"https://ror.org/05c1yfj14","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210159865"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yi Liu","raw_affiliation_strings":["Department of Hematology, Xiangya Hospital, Central South University, Changsha, China","Hunan Hematology Oncology Clinical Medical Research Center, Changsha, China","National Clinical Research Center for Geriatric Diseases (Xiangya Hospital), Changsha, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Xiangya Hospital, Central South University, Changsha, China","institution_ids":["https://openalex.org/I139660479","https://openalex.org/I4210159865"]},{"raw_affiliation_string":"Hunan Hematology Oncology Clinical Medical Research Center, Changsha, China","institution_ids":[]},{"raw_affiliation_string":"National Clinical Research Center for Geriatric Diseases (Xiangya Hospital), Changsha, China","institution_ids":["https://openalex.org/I4210159865"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067523015","display_name":"Shuanghui Yang","orcid":"https://orcid.org/0000-0002-4092-5820","observed_orcids":["https://orcid.org/0000-0002-4092-5820"]},"institutions":[{"id":"https://openalex.org/I139660479","display_name":"Central South University","ror":"https://ror.org/00f1zfq44","country_code":"CN","type":"education","lineage":["https://openalex.org/I139660479"]},{"id":"https://openalex.org/I4210159865","display_name":"Xiangya Hospital Central South University","ror":"https://ror.org/05c1yfj14","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210159865"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Shuanghui Yang","raw_affiliation_strings":["Department of Hematology, Xiangya Hospital, Central South University, Changsha, China","Hunan Hematology Oncology Clinical Medical Research Center, Changsha, China","National Clinical Research Center for Geriatric Diseases (Xiangya Hospital), Changsha, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Xiangya Hospital, Central South University, Changsha, China","institution_ids":["https://openalex.org/I139660479","https://openalex.org/I4210159865"]},{"raw_affiliation_string":"Hunan Hematology Oncology Clinical Medical Research Center, Changsha, China","institution_ids":[]},{"raw_affiliation_string":"National Clinical Research Center for Geriatric Diseases (Xiangya Hospital), Changsha, China","institution_ids":["https://openalex.org/I4210159865"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100378076","display_name":"Yan Chen","orcid":"https://orcid.org/0000-0002-3290-3357","observed_orcids":["https://orcid.org/0000-0002-3290-3357"]},"institutions":[{"id":"https://openalex.org/I139660479","display_name":"Central South University","ror":"https://ror.org/00f1zfq44","country_code":"CN","type":"education","lineage":["https://openalex.org/I139660479"]},{"id":"https://openalex.org/I4210159865","display_name":"Xiangya Hospital Central South University","ror":"https://ror.org/05c1yfj14","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210159865"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Yan Chen","raw_affiliation_strings":["Department of Hematology, Xiangya Hospital, Central South University, Changsha, China. yanchen2018@csu.edu.cn","Hunan Hematology Oncology Clinical Medical Research Center, Changsha, China. yanchen2018@csu.edu.cn","National Clinical Research Center for Geriatric Diseases (Xiangya Hospital), Changsha, China. yanchen2018@csu.edu.cn"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Xiangya Hospital, Central South University, Changsha, China. yanchen2018@csu.edu.cn","institution_ids":["https://openalex.org/I139660479","https://openalex.org/I4210159865"]},{"raw_affiliation_string":"Hunan Hematology Oncology Clinical Medical Research Center, Changsha, China. yanchen2018@csu.edu.cn","institution_ids":["https://openalex.org/I139660479"]},{"raw_affiliation_string":"National Clinical Research Center for Geriatric Diseases (Xiangya Hospital), Changsha, China. yanchen2018@csu.edu.cn","institution_ids":["https://openalex.org/I4210159865"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5114626865","display_name":"Yajing Xu","orcid":"https://orcid.org/0000-0003-2847-2547","observed_orcids":["https://orcid.org/0000-0003-2847-2547"]},"institutions":[{"id":"https://openalex.org/I139660479","display_name":"Central South University","ror":"https://ror.org/00f1zfq44","country_code":"CN","type":"education","lineage":["https://openalex.org/I139660479"]},{"id":"https://openalex.org/I4210159865","display_name":"Xiangya Hospital Central South University","ror":"https://ror.org/05c1yfj14","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210159865"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Yajing Xu","raw_affiliation_strings":["Department of Hematology, Xiangya Hospital, Central South University, Changsha, China. xyyajingxu@csu.edu.cn","Hunan Hematology Oncology Clinical Medical Research Center, Changsha, China. xyyajingxu@csu.edu.cn","National Clinical Research Center for Geriatric Diseases (Xiangya Hospital), Changsha, China. xyyajingxu@csu.edu.cn"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Xiangya Hospital, Central South University, Changsha, China. xyyajingxu@csu.edu.cn","institution_ids":["https://openalex.org/I139660479","https://openalex.org/I4210159865"]},{"raw_affiliation_string":"Hunan Hematology Oncology Clinical Medical Research Center, Changsha, China. xyyajingxu@csu.edu.cn","institution_ids":["https://openalex.org/I139660479"]},{"raw_affiliation_string":"National Clinical Research Center for Geriatric Diseases (Xiangya Hospital), Changsha, China. xyyajingxu@csu.edu.cn","institution_ids":["https://openalex.org/I4210159865"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5100378076","https://openalex.org/A5114626865"],"corresponding_institution_ids":["https://openalex.org/I139660479","https://openalex.org/I4210159865"],"apc_list":{"value":4590,"currency":"USD","value_usd":4590},"apc_paid":{"value":4590,"currency":"USD","value_usd":4590},"fwci":1.9865,"has_fulltext":true,"cited_by_count":3,"citation_normalized_percentile":{"value":0.86524471,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":97,"max":98},"biblio":{"volume":"104","issue":"7","first_page":"3753","last_page":"3762"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.7416999936103821,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.7416999936103821,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.24400000274181366,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/allogeneic-hematopoietic-stem-cell-transplantation","display_name":"allogeneic hematopoietic stem cell transplantation","score":0.9440000057220459},{"id":"https://openalex.org/keywords/cladribine","display_name":"cladribine","score":0.7620000243186951},{"id":"https://openalex.org/keywords/busulfan","display_name":"busulfan","score":0.8870000243186951},{"id":"https://openalex.org/keywords/cyclophosphamide","display_name":"cyclophosphamide","score":0.996999979019165},{"id":"https://openalex.org/keywords/conditioning-regimen","display_name":"conditioning regimen","score":0.8399999737739563},{"id":"https://openalex.org/keywords/total-body-irradiation","display_name":"total body irradiation","score":0.8849999904632568},{"id":"https://openalex.org/keywords/relapse","display_name":"relapse","score":0.6299999952316284},{"id":"https://openalex.org/keywords/treatment-related-mortality","display_name":"non-relapse mortality","score":0.906000018119812},{"id":"https://openalex.org/keywords/measurable-residual-disease","display_name":"minimal residual disease","score":0.8640000224113464},{"id":"https://openalex.org/keywords/disease-free-survival","display_name":"disease-free survival","score":0.9309999942779541}],"concepts":[{"id":"https://openalex.org/C2778041864","wikidata":"https://www.wikidata.org/wiki/Q180983","display_name":"Cytarabine","level":3,"score":0.8095794916152954},{"id":"https://openalex.org/C2780611847","wikidata":"https://www.wikidata.org/wiki/Q348922","display_name":"Busulfan","level":4,"score":0.7969413995742798},{"id":"https://openalex.org/C2779200787","wikidata":"https://www.wikidata.org/wiki/Q414030","display_name":"Cladribine","level":2,"score":0.7642645239830017},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7513154149055481},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.6962742209434509},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6204482316970825},{"id":"https://openalex.org/C194409129","wikidata":"https://www.wikidata.org/wiki/Q103824","display_name":"Hematology","level":2,"score":0.5645031929016113},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.5494427680969238},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.528967559337616},{"id":"https://openalex.org/C2779263901","wikidata":"https://www.wikidata.org/wiki/Q185916","display_name":"Fludarabine","level":4,"score":0.4836067259311676},{"id":"https://openalex.org/C2993801483","wikidata":"https://www.wikidata.org/wiki/Q1128050","display_name":"Conditioning regimen","level":4,"score":0.47466185688972473},{"id":"https://openalex.org/C2909962599","wikidata":"https://www.wikidata.org/wiki/Q180664","display_name":"Lymphoblastic Leukemia","level":3,"score":0.42070209980010986},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.3755456507205963},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.354472815990448}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002066","descriptor_name":"Busulfan","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002066","descriptor_name":"Busulfan","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D003561","descriptor_name":"Cytarabine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003561","descriptor_name":"Cytarabine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015452","descriptor_name":"Precursor B-Cell Lymphoblastic Leukemia-Lymphoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015452","descriptor_name":"Precursor B-Cell Lymphoblastic Leukemia-Lymphoma","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":true},{"descriptor_ui":"D015452","descriptor_name":"Precursor B-Cell Lymphoblastic Leukemia-Lymphoma","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D017338","descriptor_name":"Cladribine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D017338","descriptor_name":"Cladribine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D018380","descriptor_name":"Hematopoietic Stem Cell Transplantation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D018572","descriptor_name":"Disease-Free Survival","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019172","descriptor_name":"Transplantation Conditioning","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1007/s00277-025-06471-2","doi":"https://doi.org/10.1007/s00277-025-06471-2","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s00277-025-06471-2","pdf_url":"https://link.springer.com/content/pdf/10.1007/s00277-025-06471-2.pdf","source":{"id":"https://openalex.org/S163204731","display_name":"Annals of Hematology","issn_l":"0939-5555","issn":["0939-5555","1432-0584"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Hematology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:12334429","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/12334429","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12334429/pdf/277_2025_Article_6471.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Ann Hematol","raw_type":"Text"},{"id":"pmid:40643599","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/40643599","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of hematology","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1007/s00277-025-06471-2","doi":"https://doi.org/10.1007/s00277-025-06471-2","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s00277-025-06471-2","pdf_url":"https://link.springer.com/content/pdf/10.1007/s00277-025-06471-2.pdf","source":{"id":"https://openalex.org/S163204731","display_name":"Annals of Hematology","issn_l":"0939-5555","issn":["0939-5555","1432-0584"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Hematology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4412189596.pdf","grobid_xml":"https://content.openalex.org/works/W4412189596.grobid-xml"},"referenced_works_count":48,"referenced_works":["https://openalex.org/W121485390","https://openalex.org/W1784814409","https://openalex.org/W1982106371","https://openalex.org/W1982770189","https://openalex.org/W1993665924","https://openalex.org/W2005002555","https://openalex.org/W2035682141","https://openalex.org/W2047098009","https://openalex.org/W2078641935","https://openalex.org/W2090845094","https://openalex.org/W2094044857","https://openalex.org/W2109346271","https://openalex.org/W2112185457","https://openalex.org/W2289642929","https://openalex.org/W2339658711","https://openalex.org/W2342244830","https://openalex.org/W2379365975","https://openalex.org/W2509971058","https://openalex.org/W2525939690","https://openalex.org/W2529889366","https://openalex.org/W2621741324","https://openalex.org/W2737210148","https://openalex.org/W2794023929","https://openalex.org/W2794341976","https://openalex.org/W2794768267","https://openalex.org/W2801956367","https://openalex.org/W2805930313","https://openalex.org/W2883953367","https://openalex.org/W2985510842","https://openalex.org/W2987990236","https://openalex.org/W3003528460","https://openalex.org/W3013694430","https://openalex.org/W3118151373","https://openalex.org/W3119668263","https://openalex.org/W3146530070","https://openalex.org/W3159640892","https://openalex.org/W3175514571","https://openalex.org/W3184315968","https://openalex.org/W3206809420","https://openalex.org/W3211929629","https://openalex.org/W4205331543","https://openalex.org/W4223443985","https://openalex.org/W4285008946","https://openalex.org/W4285494221","https://openalex.org/W4294204223","https://openalex.org/W4295028880","https://openalex.org/W4316194093","https://openalex.org/W4408798986"],"related_works":["https://openalex.org/W4417021635","https://openalex.org/W2052661555","https://openalex.org/W3034343309","https://openalex.org/W4394785279","https://openalex.org/W4409004849","https://openalex.org/W2912225957","https://openalex.org/W3175514571","https://openalex.org/W2998296787","https://openalex.org/W4396954333","https://openalex.org/W4318777463"],"abstract_inverted_index":{"Allogeneic":[0],"hematopoietic":[1],"stem":[2],"cell":[3],"transplantation":[4,130],"(allo-HSCT)":[5],"is":[6],"the":[7,23,125,147,175,200],"most":[8],"effective":[9],"salvage":[10],"strategy":[11],"for":[12,39],"B-cell":[13],"acute":[14],"lymphoblastic":[15],"leukemia":[16],"(B-ALL).":[17],"In":[18,188],"this":[19],"study,":[20],"we":[21],"explored":[22],"efficacy":[24],"and":[25,29,79,85,110],"safety":[26],"of":[27,73,83,127,153,202],"cladribine":[28],"medium-dose":[30],"cytarabine":[31],"intensified":[32],"busulfan":[33],"plus":[34,62],"cyclophosphamide":[35,63],"conditioning":[36,191],"regimen":[37,192],"(CBAC)":[38],"high-risk":[40,145,203,210],"B-ALL":[41,204],"patients":[42,55,164],"at":[43,173,215],"complete":[44],"remission":[45],"(CR)":[46],"after":[47,129],"chemotherapy":[48],"undergoing":[49],"allo-HSCT.":[50],"And":[51],"compared":[52,131],"it":[53],"with":[54,132,165,208],"historical":[56],"received":[57],"traditional":[58],"total":[59],"body":[60],"irradiation":[61],"(TBI-Cy)":[64],"regimen.":[65],"The":[66],"3-year":[67,155,180],"non-relapse":[68],"mortality":[69],"(NRM),":[70],"cumulative":[71],"incidence":[72],"relapse":[74,128,195],"(CIR),":[75],"disease-free":[76],"survival":[77,81],"(DFS)":[78],"overall":[80],"(OS)":[82],"CBAC":[84,133,148,176,190],"TBI-Cy":[86,123],"group":[87,149,177],"were":[88],"15.0%":[89],"vs.":[90,97,104,112],"11.1%":[91],"(":[92,99,106,114],"p":[93,100,107,115,136,160,185],"=":[94,101,108,116,137,161,186],"0.576),":[95],"17.3%":[96],"35.7%":[98],"0.077),":[102],"67.7%":[103],"53.2%":[105],"0.235)":[109],"74.3%":[111],"66.8%":[113],"0.482).":[117],"Overall":[118],"cohort":[119],"multivariate":[120],"analysis":[121,140],"indicated":[122],"increased":[124],"risk":[126],"(HR:":[134],"2.544,":[135],"0.049).":[138],"Subgroup":[139],"revealed":[141],"that":[142],"among":[143],"cytogenetic":[144,209],"patients,":[146,205],"showed":[150,178],"a":[151],"trend":[152],"higher":[154,179],"DFS":[156,181],"(75.1%":[157],"vs":[158,183],"52.6%,":[159],"0.073).":[162],"Among":[163],"minimal":[166],"residual":[167],"disease":[168],"positive":[169],"(MRD":[170],"+":[171,214],")":[172],"transplantation,":[174],"(60.0%":[182],"11.1%,":[184],"0.018).":[187],"conclusion,":[189],"may":[193],"reduce":[194],"without":[196],"increasing":[197],"NRM,":[198],"improving":[199],"prognosis":[201],"especially":[206],"those":[207],"factors":[211],"or":[212],"MRD":[213],"transplantation.":[216]},"counts_by_year":[{"year":2026,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2025-10-10T00:00:00"}